Document is current
Any future updates will be listed below
-
Authors
Perlis, Roy H.
Goldberg, Joseph F.
Ostacher, Michael J. http://orcid.org/0000-0003-0353-7535
Schneck, Christopher D.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (RF1MH132335, R01MH123804)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
- License Information
-
More Information
Article History
Received: 11 January 2024
Revised: 27 February 2024
Accepted: 29 February 2024
First Online: 13 March 2024
Competing interests
: RHP has served on scientific advisory boards or received consulting fees from Alkermes, Circular Genomics, Genomind, Psy Therapeutics, Swan AI Studios, and Vault Health. He holds equity in Circular Genomics, Psy Therapeutics, Swan AI Studios, and Vault Health. He is a paid Associate Editor at JAMA Network-Open. JFG is a Consultant at Alkermes, Genomind, Luye Pharma, Neurelis, Neuroma, Otsuka, Sunovion, Supernus; serves on speakers bureaus for Alkermes, Axsome, Intracellular; receives royalties from American Psychiatric Publishing, Cambridge University Press. MJO is a full-time employee of the United States Department of Veterans Affairs. He has received grant funding from Otsuka and Freespira; payment from Neurocrine for service on a Data Safety and Monitoring Committee; and personal payments for expert testimony. CDS reports no competing interests.
